Expression of constitutively activated EGFRvlll in non‐small cell lung cancer
- 1 January 2003
- journal article
- Published by Wiley in Cancer Science
- Vol. 94 (1) , 50-56
- https://doi.org/10.1111/j.1349-7006.2003.tb01351.x
Abstract
The epidermal growth factor receptor (EGFR) variant type III (variously called EGFRvlll, de2–7 EGFR or ΔGFR) has an in‐frame deletion of the extracellular domain and is found in numerous types of human tumors. Since EGFRvlll has been reported to be tumorspecific and has oncogenic potential, it is being investigated as a potential therapeutic target. Because the cell‐specific expression of EGFRvlll in lung has not been well documented, we examined the expression of EGFRvlll in 76 non‐small cell lung cancers (NSCLCs) and 10 non‐neoplastic lung tissues by immunohistochemistry using a new monoclonal antibody specific for this variant receptor. We found a higher incidence (30 of 76, 39%) of enhanced EGFRvlll expression in NSCLC than previously described. Interestingly, the presence of EGFRvlll was also observed in several normal tissue components of lung (e.g., normal bronchial epithelium). Given the high prevalence of EGFRvlll in NSCLC, a newly developed phospho‐specific (activated) EGFR antibody was employed for immunohistochemical analysis that permitted visualization of activated EGFR and/or EGFRvlll in tumors. This study presents evidence, for the first time, that EGFRvlll expressed in human tumors is phosphorylated and hence activated. Our results suggest that the sustained activation of EGFRvlll is implicated in the pathogenesis of NSCLC and thus EGFRvlll is a potential therapeutic target in this challenging disease. (Cancer Sci 2003; 94: 50–56)This publication has 22 references indexed in Scilit:
- Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient SurvivalJNCI Journal of the National Cancer Institute, 1998
- A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.Proceedings of the National Academy of Sciences, 1994
- Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails.Proceedings of the National Academy of Sciences, 1992
- Structural alterations of the epidermal growth factor receptor gene in human gliomas.Proceedings of the National Academy of Sciences, 1992
- Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas.Proceedings of the National Academy of Sciences, 1990
- Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumors.Molecular and Cellular Biology, 1988
- Epidermal-Growth-Factor-Dependent Transformation by a Human EGF Receptor Proto-OncogeneScience, 1987
- Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cellsCell, 1987
- Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification.Proceedings of the National Academy of Sciences, 1987
- Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial originNature, 1985